Hazard function survival analysis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Lymph Nodes Bile Ducts, Intrahepatic Cells, Cultured

Organisms2

Strongylida Mice, Inbred C57BL

Diseases60

Breast Neoplasms Neoplasm Recurrence, Local Disease Progression Recurrence Lung Neoplasms Lymphatic Metastasis Adenocarcinoma Liver Neoplasms Colorectal Neoplasms Brain Neoplasms Carcinoma, Squamous Cell Neoplasm Metastasis Carcinoma Prosthesis Failure Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Invasiveness Ovarian Neoplasms Neoplasms Kidney Failure, Chronic Carcinoma, Hepatocellular Glioblastoma Postoperative Complications Melanoma Esophageal Neoplasms Pancreatic Neoplasms Prostatic Neoplasms Kidney Neoplasms Cardiovascular Diseases Skin Neoplasms Rectal Neoplasms Heart Failure Cholangiocarcinoma Bone Neoplasms Stroke Myocardial Infarction HIV Infections Glioma Nasopharyngeal Neoplasms Carcinoma, Renal Cell Head and Neck Neoplasms Bile Duct Neoplasms Astrocytoma Colonic Neoplasms Osteosarcoma Inhalant Abuse Urinary Bladder Neoplasms Endometrial Neoplasms Chronic Disease Carcinoma, Ductal, Breast Multiple Myeloma Sarcoma Genetic Predisposition to Disease Coronary Disease Carcinoma, Transitional Cell Mouth Neoplasms Lymphoma, Large B-Cell, Diffuse Acquired Immunodeficiency Syndrome Lymphoma, Non-Hodgkin Acute Disease

Chemicals and Drugs23

Tumor Markers, Biological Antineoplastic Agents Ki-67 Antigen Cisplatin Fluorouracil Biological Markers Cyclophosphamide Receptor, erbB-2 Receptors, Estrogen Doxorubicin Tumor Suppressor Protein p53 Neoplasm Proteins Receptors, Progesterone Hazardous Substances Prednisone Vincristine RNA, Messenger Antibodies, Monoclonal Antineoplastic Agents, Hormonal Proto-Oncogene Proteins Immunosuppressive Agents Tumor Suppressor Proteins Receptor, Epidermal Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment106

Survival Analysis Proportional Hazards Models Biometry Models, Statistical Survival Rate Likelihood Functions Kaplan-Meier Estimate Prognosis Disease-Free Survival Follow-Up Studies Treatment Outcome Retrospective Studies Risk Factors Neoplasm Staging Multivariate Analysis Cohort Studies Prospective Studies Predictive Value of Tests Risk Assessment Immunohistochemistry Incidence Registries Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Life Tables Chemotherapy, Adjuvant Cause of Death Longitudinal Studies Regression Analysis Risk Tissue Array Analysis Neoplasm Grading Prosthesis Failure Reoperation Chi-Square Distribution SEER Program Mortality Analysis of Variance Probability Severity of Illness Index Biostatistics Radiotherapy, Adjuvant Gene Expression Profiling Treatment Failure Confidence Intervals Actuarial Analysis Kidney Transplantation Renal Dialysis Drug Administration Schedule Logistic Models Randomized Controlled Trials as Topic Neoadjuvant Therapy Data Interpretation, Statistical Case-Control Studies Odds Ratio Statistics, Nonparametric Immunoenzyme Techniques Epidemiologic Methods Cementation ROC Curve Hip Prosthesis Tumor Burden Reverse Transcriptase Polymerase Chain Reaction Remission Induction Liver Transplantation Prosthesis Design Transplantation, Homologous Reproducibility of Results Oligonucleotide Array Sequence Analysis Patient Selection Life Expectancy Drug Therapy, Combination Breeding Multicenter Studies as Topic Propensity Score Endpoint Determination Questionnaires Chemoradiotherapy Clinical Trials as Topic Double-Blind Method Lymph Node Excision Mitotic Index CD4 Lymphocyte Count Prevalence Hepatectomy Sensitivity and Specificity Statistical Distributions Chemoembolization, Therapeutic Models, Biological Blotting, Western Hospitalization Heart Transplantation Palliative Care Linear Models Knee Prosthesis Radiotherapy Arthroplasty, Replacement, Hip Gastrectomy Cystectomy Cluster Analysis Hospital Mortality Peritoneal Dialysis Body Mass Index Esophagectomy Polymerase Chain Reaction Population Surveillance

Psychiatry and Psychology3

Cannibalism Smoking Inhalant Abuse

Phenomena and Processes29

Time Factors Cell Survival Graft Survival Risk Gene Expression Regulation, Neoplastic Chi-Square Distribution Apoptosis Probability Longevity Mutation Signal Transduction Cell Proliferation Odds Ratio Genotype Graft Rejection Pregnancy Breeding CD4 Lymphocyte Count Dose-Response Relationship, Drug Sensitivity and Specificity Statistical Distributions Polymorphism, Single Nucleotide Algorithms Vascular Patency Genetic Predisposition to Disease Up-Regulation Body Mass Index Phenotype Drug Resistance, Neoplasm

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena5

Survival Age Distribution Socioeconomic Factors Sex Distribution Quality of Life

Humanities1

Quality of Life

Information Science15

Survival Rate Computer Simulation Incidence Registries Life Tables Cause of Death SEER Program Mortality Databases, Factual Data Interpretation, Statistical Life Expectancy Questionnaires Prevalence Algorithms Hospital Mortality

Named Groups6

Infant, Newborn Patient Dropouts Survivors European Continental Ancestry Group African Americans Asian Continental Ancestry Group

Health Care69

Survival Analysis Proportional Hazards Models Biometry Models, Statistical Survival Rate Likelihood Functions Kaplan-Meier Estimate Disease-Free Survival Follow-Up Studies Treatment Outcome Retrospective Studies Risk Factors Multivariate Analysis Cohort Studies Prospective Studies Predictive Value of Tests Risk Assessment Age Factors Incidence Registries Life Tables Cause of Death Longitudinal Studies Regression Analysis Risk Sex Factors Chi-Square Distribution SEER Program Mortality Analysis of Variance Probability Severity of Illness Index Age of Onset Comorbidity Treatment Failure Confidence Intervals Actuarial Analysis Logistic Models Randomized Controlled Trials as Topic Data Interpretation, Statistical Case-Control Studies Odds Ratio Statistics, Nonparametric Epidemiologic Methods ROC Curve Age Distribution Reproducibility of Results Patient Selection Bias (Epidemiology)Life Expectancy Multicenter Studies as Topic Propensity Score Questionnaires Clinical Trials as Topic Double-Blind Method Prevalence Socioeconomic Factors Outcome Assessment (Health Care)Sex Distribution Sensitivity and Specificity Statistical Distributions Hospitalization Palliative Care Linear Models Cluster Analysis Confounding Factors (Epidemiology)Hospital Mortality Body Mass Index Population Surveillance

Geographicals16

United States Japan Europe Sweden France Denmark Italy Taiwan Spain China Macau Netherlands California Finland Australia Iran

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Survival Analysis Proportional Hazards Models Biometry Models, Statistical Survival Rate Likelihood Functions Time Factors Computer Simulation Cell Survival Kaplan-Meier Estimate Prognosis Disease-Free Survival Follow-Up Studies Treatment Outcome Retrospective Studies Survival Risk Factors Neoplasm Staging Multivariate Analysis Cohort Studies Prospective Studies Graft Survival Tumor Markers, Biological Predictive Value of Tests Breast Neoplasms Risk Assessment Age Factors Immunohistochemistry Incidence Neoplasm Recurrence, Local Registries Disease Progression Recurrence Lung Neoplasms Lymphatic Metastasis Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Life Tables Adenocarcinoma United States Chemotherapy, Adjuvant Cause of Death Longitudinal Studies Liver Neoplasms Colorectal Neoplasms Regression Analysis Risk Tissue Array Analysis Brain Neoplasms Neoplasm Grading Carcinoma, Squamous Cell Neoplasm Metastasis Sex Factors Carcinoma Prosthesis Failure Gene Expression Regulation, Neoplastic Reoperation Chi-Square Distribution Antineoplastic Agents SEER Program Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Invasiveness Ovarian Neoplasms Neoplasms Kidney Failure, Chronic Mortality Apoptosis Analysis of Variance Probability Severity of Illness Index Biostatistics Radiotherapy, Adjuvant Longevity Carcinoma, Hepatocellular Age of Onset Comorbidity Ki-67 Antigen Cell Line, Tumor Glioblastoma Postoperative Complications Gene Expression Profiling Melanoma Treatment Failure Confidence Intervals Actuarial Analysis Esophageal Neoplasms Kidney Transplantation Renal Dialysis Cisplatin Databases, Factual Drug Administration Schedule Fluorouracil Pancreatic Neoplasms Mutation Prostatic Neoplasms Biological Markers Cyclophosphamide Logistic Models Infant, Newborn

No FAQ available that match "hazard function survival analysis"